Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Davis Stephen
Relationship:   Director
City:   Branford
State:   CT
   
Insider Summary:
  
   
Companies Owned :   5    
Direct Shares   344,117    

Indirect Shares

   0      
Direct Value   $2,518,205    

Indirect Value

   $0      
Total Shares   344,117      
Total Value   $2,518,205      


Heron Therapeutics Inc $179,510 Acadia Pharmaceuticals Inc $2,328,465 Bellicum Pharmaceuticals, Inc $10,230 Heron Therapeutics Inc $179,510 Acadia Pharmaceuticals Inc $2,328,465 Bellicum Pharmaceuticals, Inc $10,230
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    16    

     Stock price went up :
    0   
    7    
     Stock price went down :
    0   
    9    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
 -93.8%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Heron Therapeutics Inc HRTX Director 2022-12-16 52,032 2010-02-17 0    Premium*  
            Ardea Biosciences Inc RDEA EVP & COO 2012-06-19 0 2010-04-06 0    Premium*  
            Furiex Pharmaceuticals, Inc. FURX Director 2014-07-02 0 2013-05-24 0    Premium*  
            Acadia Pharmaceuticals Inc ACAD 2024-05-02 155,231 2019-10-09 0    Premium*  
            Bellicum Pharmaceuticals, Inc BLCM Director 2023-01-03 136,854 2022-01-04 0    Premium*  
* Premium Members only  

Records found :    95         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 2 of 4
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
ACAD Acadia Pharmaceuticals In... CEO   •       •      –    2022-01-06 4 OE $0.00 $0 D/D 9,527 62,434 0 -
ACAD Acadia Pharmaceuticals In... CEO   •       •      –    2022-02-23 4 S $23.80 $93,486 D/D (3,928) 65,733 0 %
ACAD Acadia Pharmaceuticals In... CEO   •       •      –    2022-02-23 4 OE $0.00 $0 D/D 10,945 69,661 0 -
ACAD Acadia Pharmaceuticals In... CEO   •       •      –    2022-04-29 4 OE $0.00 $0 D/D 15,625 81,358 0 -
ACAD Acadia Pharmaceuticals In... CEO   •       •      –    2022-05-02 4 S $18.18 $99,691 D/D (5,483) 75,875 0 %
ACAD Acadia Pharmaceuticals In... CEO   •       •      –    2022-10-15 4 S $15.81 $44,331 D/D (2,804) 79,009 0 %
ACAD Acadia Pharmaceuticals In... CEO   •       •      –    2022-10-15 4 OE $0.00 $0 D/D 5,938 81,813 0 -
ACAD Acadia Pharmaceuticals In... CEO   •       •      –    2023-01-06 4 OE $0.00 $0 D/D 9,528 88,537 0 -
ACAD Acadia Pharmaceuticals In... CEO   •       •      –    2023-01-09 4 S $17.13 $66,877 D/D (3,904) 84,633 0 %
ACAD Acadia Pharmaceuticals In... CEO   •       •      –    2023-02-23 4 OE $0.00 $0 D/D 10,945 95,578 0 -
ACAD Acadia Pharmaceuticals In... CEO   •       •      –    2023-02-24 4 S $18.78 $72,322 D/D (3,851) 91,727 0 %
ACAD Acadia Pharmaceuticals In... CEO   •       •      –    2023-04-05 4 OE $0.00 $0 D/D 17,333 109,060 0 -
ACAD Acadia Pharmaceuticals In... CEO   •       •      –    2023-04-06 4 S $18.16 $155,849 D/D (8,582) 100,478 0 %
ACAD Acadia Pharmaceuticals In... CEO   •       •      –    2023-04-29 4 OE $0.00 $0 D/D 15,625 116,103 0 -
ACAD Acadia Pharmaceuticals In... CEO   •       •      –    2023-05-01 4 S $21.18 $165,331 D/D (7,806) 108,297 0 %
ACAD Acadia Pharmaceuticals In... CEO   •       •      –    2023-07-11 4 AS $25.00 $412,450 D/D (16,498) 91,799 0 %
ACAD Acadia Pharmaceuticals In... CEO   •       •      –    2023-07-12 4 AS $25.05 $1,380,449 D/D (55,104) 36,695 0 %
ACAD Acadia Pharmaceuticals In... CEO   •       •      –    2023-07-14 4 AS $30.04 $3,004,350 D/D (100,000) 36,695 0 %
ACAD Acadia Pharmaceuticals In... CEO   •       •      –    2023-07-14 4 OE $20.77 $2,077,000 D/D 100,000 136,695 0 -
ACAD Acadia Pharmaceuticals In... CEO   •       •      –    2023-10-05 4 OE $0.00 $0 D/D 103,999 140,694 0 -
ACAD Acadia Pharmaceuticals In... CEO   •       •      –    2023-10-06 4 S $21.96 $1,132,323 D/D (51,563) 89,131 0 %
ACAD Acadia Pharmaceuticals In... CEO   •       •      –    2024-01-06 4 OE $0.00 $0 D/D 9,528 100,253 0 -
ACAD Acadia Pharmaceuticals In... CEO   •       •      –    2024-01-08 4 S $29.96 $111,811 D/D (3,732) 96,521 0 %
ACAD Acadia Pharmaceuticals In... CEO   •       •      –    2024-02-23 4 OE $0.00 $0 D/D 10,946 107,467 0 -
ACAD Acadia Pharmaceuticals In... CEO   •       •      –    2024-02-26 4 AS $24.67 $137,585 D/D (5,577) 101,890 0 %
  95  Records found
  1   2  3   4      
  Page 2 of 4  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us